verified SJR 0,468 · Q2 • database Scopus / SJR & Web of Science indexed

India · Wolters Kluwer Medknow Publi...

workspace_premium Q2 — Medicine (miscellaneous) visibility_off Double blind peer review lock_open Open Access

Journal of Cancer Research and Therapeutics

Journal of Cancer Research and Therapeutics is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 55. It is an CC BY-NC-SA Journal with a Double blind peer review review system, and It has a price of 1350 €. The scope of the journal is focused on oncology, radiation oncology, radiobiology, medical oncology. It has an SJR impact factor of 0,468 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,468.

ISSN: 0973-1482

Publisher: Wolters Kluwer Medknow Publications

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Author guidelines

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,468 Q2

H-index 55

Acceptance rate pie_chart

32%

Source Acceptance_Rate

Time to publication hourglass_top

25 weeks

Field Average_time_publication_weeks

Publication cost (APC) payments

1.350 € Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,468

H-index

Docs (year)

379

Docs 3y

1227

Total refs

9427

Cites 3y

1682

Citable 3y

1173

Cites/Doc 2y

1.18

Ref/Doc

24.87

Immediate OA

1350 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Association of hypoxia-inducible factor-1 alpha gene polymorphism with renal cell carcinoma susceptibility

Vimentin positive acantholytic penile squamous cell carcinoma with rhabdoid features

Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: A phase II study

Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

Comparative retrospective analysis of locoregional recurrence in unselected breast cancer patients treated with conventional versus hypofractionated radiotherapy at a tertiary cancer center?

Chondrosarcoma of the distal phalanx of the right great toe: Report of a rare malignancy and review of literature

Cavitary mucoepidermoid carcinoma of lung with metastases in skeletal muscles as presenting features: A case report and review of the literature

Cardiotoxic effects of radiotherapy and strategies to reduce them in patients with breast cancer: An overview

Cardiac involvement in melanoma: A case report and review of the literature

Carcinoma colon presenting as cutaneous metastasis to an old operative scar of hysterectomy

Cancer care in the rural areas of India: A firsthand experience of a clinical oncologist and review of literatures

Bone metastasis

SHOW MORE ARTICLES

Bilateral renal metastases in a case of Merkel cell carcinoma

"A critique of ""American Brachytherapy Society Survey of three-dimensional imaging in gynecologic brachytherapy"

Association between hepatitis B virus/hepatitis C virus infection and primary hepatocellular carcinoma risk: A meta-analysis based on Chinese population

Assessment of compliance to treatment and efficacy of a resource-sparing hypofractionated radiotherapy regimen in patients with poor-prognosis high-grade gliomas

Art in the time of disease

Analysis of the chromosomal aneuploidy by interphase fluorescence in situ hybridization (FISH) in Squamous cell carcinoma of the cervix in Jammu region of J and K state

Analysis of prognostic factors in 1180 patients with oral cavity primary cancer treated with definitive or adjuvant radiotherapy

An unusual case of cavernous haemangioma of the Fallopian tube

An acute unusual presentation of hepatocellular carcinoma

Aggressive angiomyxoma of greater omentum with pleural effusion in a young male

Adult neuroblastoma of the ovary: A rare tumor with review of literature

A rarely seen mucoepidermoid carcinoma of the left main bronchus

FAQs

Journal of Cancer Research and Therapeutics has an SJR of 0,468 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 1350 EUR.

The acceptance rate recorded for Journal of Cancer Research and Therapeutics is 32%.

Journal of Cancer Research and Therapeutics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Cancer Research and Therapeutics?

What is the APC / publication cost?

What is the acceptance rate?